Thrombogenicity and Antithrombotic Strategies in Structural Heart Interventions and Nonaortic Cardiac Device Therapy—Current Evidence and Practice
暂无分享,去创建一个
K. Huber | J. Schreieck | M. Gawaz | J. T. ten Berg | D. Sibbing | R. Storey | D. Gorog | T. Geisler | D. Rath | A. Rubboli | D. Aradi | S. Kristensen | A. Popov | P. Seizer | M. Droppa | R. Jorbenadze | K. Mueller | Diana A Gorog
[1] H. Katus,et al. Temporary oral anticoagulation after MitraClip – a strategy to lower the incidence of post-procedural stroke? , 2020, Acta cardiologica.
[2] M. Hannan,et al. 2019 EACTS Expert Consensus on long-term mechanical circulatory support , 2019, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[3] J. Tobis,et al. New-onset atrial fibrillation following percutaneous patent foramen ovale closure: a systematic review and meta-analysis of randomised trials. , 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[4] A. Garan,et al. Use of Cangrelor during Venoarterial Extracorporeal Membrane Oxygenation Following Percutaneous Coronary Intervention , 2019, The Journal of Heart and Lung Transplantation.
[5] Deepak L. Bhatt,et al. Cangrelor in cardiogenic shock and after cardiopulmonary resuscitation: A global, multicenter, matched pair analysis with oral P2Y12 inhibition from the IABP-SHOCK II trial. , 2019, Resuscitation.
[6] T. Hohlfeld,et al. Antiplatelet effects of aspirin and clopidogrel after left atrial appendage (LAA) occluder implantation. , 2019, International journal of cardiology.
[7] W. Rottbauer,et al. Apixaban After Percutaneous Edge-to-Edge Mitral Valve Repair in Patients With Maintained Sinus Rhythm. , 2019, JACC. Cardiovascular interventions.
[8] B. Meier,et al. European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism. , 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[9] J. T. ten Berg,et al. Percutaneous patent foramen ovale closure using the Occlutech Figulla device: More than 1,300 patient‐years of follow up , 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[10] P. Garot,et al. Device-Related Thrombus After Left Atrial Appendage Closure , 2018, Interventional cardiology.
[11] P. Voisine,et al. Transcatheter Mitral-Valve Repair in Patients with Heart Failure. , 2019, The New England journal of medicine.
[12] F. Laurent,et al. Left atrial appendage patency and device-related thrombus after percutaneous left atrial appendage occlusion: a computed tomography study , 2018, European heart journal cardiovascular Imaging.
[13] B. Meier,et al. European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism. , 2018, European heart journal.
[14] P. Risteski,et al. Repeat left ventricular assist device exchange with inflow or outflow correction for recurrent pump thrombosis and cerebral haemorrhage through limited incisions. , 2018, European Journal of Cardio-Thoracic Surgery.
[15] L. Prahl Wittberg,et al. Flow-induced platelet activation in components of the extracorporeal membrane oxygenation circuit , 2018, Scientific Reports.
[16] V. Reddy,et al. Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes , 2018, Circulation.
[17] D. Maucort-Boulch,et al. Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation , 2018, The New England journal of medicine.
[18] J. Healey,et al. Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2) , 2018, European heart journal.
[19] G. Guyatt,et al. Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline , 2018, British Medical Journal.
[20] B. Kiaii,et al. Thrombus in a Hypercoagulable Patient Following Patent Foramen Ovale Closure With the Gore Septal Occluder. , 2018, JACC. Cardiovascular interventions.
[21] A. Camm,et al. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. , 2018, European heart journal.
[22] Pascal Defaye,et al. Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation. , 2018, Journal of the American College of Cardiology.
[23] R. Patten,et al. High Thromboembolic Event Rate in Patients Supported With an Impella CP Device With an Anti-Xa Level of Less Than 0.1 u/mL , 2018 .
[24] James W Long,et al. Two‐Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure , 2018, The New England journal of medicine.
[25] S. Bangalore,et al. Device Thrombosis After Percutaneous Left Atrial Appendage Occlusion Is Related to Patient and Procedural Characteristics but Not to Duration of Postimplantation Dual Antiplatelet Therapy , 2018, Circulation. Cardiovascular interventions.
[26] M. Gawaz,et al. Formation of a left atrial thrombus during percutaneous mitral valve edge-to-edge repair induced by acute reduction of mitral regurgitation. , 2018, Journal of cardiology cases.
[27] R. Formigari,et al. Recurrent Stroke after Transcatheter PFO Closure in Cryptogenic Stroke or Tia: Long-Term Follow-Up , 2017, Cardiology research and practice.
[28] Xavier Freixa,et al. Device‐associated thrombus formation after left atrial appendage occlusion: A systematic review of events reported with the Watchman, the Amplatzer Cardiac Plug and the Amulet , 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[29] T. Potpara,et al. Left atrial appendage occluder implantation in Europe: indications and anticoagulation post-implantation. Results of the European Heart Rhythm Association Survey , 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[30] Jeroen J. Bax,et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. , 2017, European heart journal.
[31] Helle K. Iversen,et al. Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke , 2017, The New England journal of medicine.
[32] David E. Thaler,et al. Long‐Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke , 2017, The New England journal of medicine.
[33] Jean-Marc Schleich,et al. Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke , 2017, The New England journal of medicine.
[34] S. Kubo,et al. Incidence, Characteristics, and Clinical Course of Device-Related Thrombus After Watchman Left Atrial Appendage Occlusion Device Implantation in Atrial Fibrillation Patients. , 2017, JACC. Clinical electrophysiology.
[35] Dnp,et al. Thrombotic valvular dysfunction with transcatheter mitral interventions for postsurgical failures , 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[36] L. Fleisher,et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2017, Journal of the American College of Cardiology.
[37] B. Meier,et al. Patients with intracranial bleeding and atrial fibrillation treated with left atrial appendage occlusion: Results from the Amplatzer Cardiac Plug registry. , 2017, International journal of cardiology.
[38] J. Granada,et al. Transcatheter Mitral Valve Replacement: Insights From Early Clinical Experience and Future Challenges. , 2017, Journal of the American College of Cardiology.
[39] J. Bauersachs,et al. First series of left ventricular assist device exchanges to HeartMate 3 , 2017, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[40] E. Horváth-Puhó,et al. Risk of Stroke in Patients With Heart Failure: A Population-Based 30-Year Cohort Study , 2017, Stroke.
[41] J. Deharo,et al. An Oscillating Mass Attached to a Pacemaker Lead: Thrombus or Vegetation? A Fishing Story. , 2017, JACC Clinical Electrophysiology.
[42] U. Ziemann,et al. Thromboembolic Risk Reduction Via Transseptal Thrombus Aspiration in a Patient With Spontaneous Left Atrial Thrombus and Stroke. , 2017, JACC. Cardiovascular interventions.
[43] J. Saw,et al. Incidence and Clinical Impact of Device-Associated Thrombus and Peri-Device Leak Following Left Atrial Appendage Closure With the Amplatzer Cardiac Plug. , 2017, JACC. Cardiovascular interventions.
[44] J. Weitz,et al. Factors XI and XII as Targets for New Anticoagulants , 2017, Front. Med..
[45] V. Rao,et al. Ventricular Thrombosis Post-Venoarterial Extracorporeal Membrane Oxygenation. , 2017, Circulation. Heart failure.
[46] Valluvan Jeevanandam,et al. Intrapericardial Left Ventricular Assist Device for Advanced Heart Failure , 2017, The New England journal of medicine.
[47] M. Ozaki,et al. Changes in heparin dose response slope during cardiac surgery: possible result in inaccuracy in predicting heparin bolus dose requirement to achieve target ACT , 2017, Perfusion.
[48] J. Leipsic,et al. Transcatheter Mitral Valve Replacement for Patients With Symptomatic Mitral Regurgitation: A Global Feasibility Trial. , 2017, Journal of the American College of Cardiology.
[49] G. Nickenig,et al. Thrombus Formation After Left Atrial Appendage Occlusion With the Amplatzer Amulet Device. , 2017, JACC. Clinical electrophysiology.
[50] Roxana Mehran,et al. Prosthetic Heart Valve Thrombosis. , 2016, Journal of the American College of Cardiology.
[51] C. Kemaloğlu,et al. Thrombosis in Continuous Flow Left Ventricular Assist Devices: Our Clinical Experience With Medical and Surgical Management. , 2016, Transplantation proceedings.
[52] B. Meier,et al. Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug. , 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[53] S. Kische,et al. Percutaneous left atrial appendage occlusion: Device thrombosis in clopidogrel non-responders. , 2016, International journal of cardiology.
[54] R. Virmani,et al. Cerebral Protection During MitraClip Implantation: Initial Experience at 2 Centers. , 2016, JACC. Cardiovascular interventions.
[55] V. Kocka,et al. Periprocedural antithrombotic therapy during various types of percutaneous cardiovascular interventions , 2015, European heart journal. Cardiovascular pharmacotherapy.
[56] P. Boekstegers,et al. One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registry , 2015, European heart journal.
[57] P. Boekstegers,et al. Risk and outcomes of complications during and after MitraClip implantation: Experience in 828 patients from the German TRAnscatheter mitral valve interventions (TRAMI) registry , 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[58] Leway Chen,et al. Factors Related to Pump Thrombosis With the Heartmate II Left Ventricular Assist Device , 2015, Journal of cardiac surgery.
[59] G. Wieselthaler,et al. Antithrombotic therapy for left ventricular assist devices in adults: a systematic review , 2015, Journal of thrombosis and haemostasis : JTH.
[60] J. Hirsh,et al. Medical device‐induced thrombosis: what causes it and how can we prevent it? , 2015, Journal of thrombosis and haemostasis : JTH.
[61] T. Potpara,et al. Left atrial appendage closure-indications, techniques, and outcomes: results of the European Heart Rhythm Association Survey. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[62] S. Bertog,et al. Incomplete left atrial appendage occlusion and thrombus formation after Watchman implantation treated with anticoagulation followed by further transcatheter closure with a second‐generation Amplatzer Cardiac Plug (Amulet device) , 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[63] H. Ghanbari,et al. Antithrombotic Therapy and Outcomes After ICD Implantation in Patients With Atrial Fibrillation and Coronary Artery Disease: An Analysis From the National Cardiovascular Data Registry (NCDR)® , 2015, Journal of the American Heart Association.
[64] L. Sylvia,et al. Bivalirudin for Treatment of LVAD Thrombosis: A Case Series , 2014, ASAIO journal.
[65] B. Meier,et al. EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[66] M. Huntgeburth,et al. Thrombus formation at the MitraClip system during percutaneous mitral valve repair. , 2014, JACC. Cardiovascular interventions.
[67] J. Mehilli,et al. Dangerous liaison: successful percutaneous edge-to-edge mitral valve repair in patients with end-stage systolic heart failure can cause left ventricular thrombus formation. , 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[68] T. Meinertz,et al. Predictors of recurrent stroke after percutaneous closure of patent foramen ovale. , 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[69] Michael J. Wilson,et al. A Factor XIIa Inhibitory Antibody Provides Thromboprotection in Extracorporeal Circulation Without Increasing Bleeding Risk , 2014, Science Translational Medicine.
[70] G. Felker,et al. Thrombolytic therapy for thrombosis of continuous flow ventricular assist devices. , 2014, Journal of cardiac failure.
[71] G. Ailawadi,et al. Diagnosis, Nonsurgical Management, and Prevention of LVAD Thrombosis , 2014, Journal of cardiac surgery.
[72] S. Chaparro,et al. Argatroban as novel therapy for suspected thrombosis in patients with continuous-flow left ventricle assist device and hemolysis. , 2014, ASAIO journal.
[73] S. Prasad,et al. The use of eptifibatide for suspected pump thrombus or thrombosis in patients with left ventricular assist devices. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[74] Sean Pinney,et al. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[75] G. Ewald,et al. Unexpected abrupt increase in left ventricular assist device thrombosis. , 2014, The New England journal of medicine.
[76] Y. Alsancak,et al. PEDIATRIC AND CONGENITAL HEART DISEASE Original Studies Short and Long Term Complications of Device Closure of Atrial Septal Defect and Patent Foramen Ovale: Meta-Analysis of 28,142 Patients From 203 Studies , 2013 .
[77] P. Azadani,et al. Risk Factors and Prognosis for Clot Formation on Cardiac Device Leads , 2013, Pacing and clinical electrophysiology : PACE.
[78] A. Diegeler,et al. Stroke and thrombus formation appending to the MitraClip: what is the appropriate anticoagulation regimen? , 2013, The Journal of heart valve disease.
[79] A. Curnis,et al. Right giant atrial thrombosis and pulmonary embolism complicating pacemaker leads , 2013, BMJ Case Reports.
[80] S. Russell,et al. Algorithm for the diagnosis and management of suspected pump thrombus. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[81] Petr Neuzil,et al. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology). , 2013, Journal of the American College of Cardiology.
[82] Atul Verma,et al. Pacemaker or defibrillator surgery without interruption of anticoagulation. , 2013, The New England journal of medicine.
[83] K. Muthiah,et al. Thrombolysis for suspected intrapump thrombosis in patients with continuous flow centrifugal left ventricular assist device. , 2013, Artificial organs.
[84] F. Mohr,et al. Fluoroscopy-Guided Resolution of Ingested Thrombus Leading to Functional Disturbance of a Continuous-Flow Left Ventricular Assist Device , 2012, Case reports in surgery.
[85] D. Kahali,et al. Permanent Pacemaker‐Related Upper Extremity Deep Vein Thrombosis: A Series of 20 Cases , 2012, Pacing and clinical electrophysiology : PACE.
[86] Jennifer Taylor,et al. ESC/EACTS Guidelines on the management of valvular heart disease. , 2012, European heart journal.
[87] Marissa Miller,et al. Long-term mechanical circulatory support (destination therapy): on track to compete with heart transplantation? , 2012, The Journal of thoracic and cardiovascular surgery.
[88] B. Balkau,et al. Short-acting P2Y12 blockade to reduce platelet dysfunction and coagulopathy during experimental extracorporeal circulation and hypothermia. , 2012, British journal of anaesthesia.
[89] J. Wöhrle,et al. PFO closuRE and CryptogenIc StrokE (PRECISE) registry: a multi-center, international registry , 2012, Clinical Research in Cardiology.
[90] S. Klotz,et al. Late left atrial thrombosis of an Amplatzer patent foramen ovale occluder. , 2011, Journal of Thoracic and Cardiovascular Surgery.
[91] F. Marchlinski,et al. Mobile Thrombus on Device Leads in Patients Undergoing Ablation: Identification, Incidence, Location, and Association With Increased Pulmonary Artery Systolic Pressure , 2011, Circulation.
[92] W. Rottbauer,et al. Large atrial thrombus formation after MitraClip implantation: is anticoagulation mandatory? , 2011, The Journal of heart valve disease.
[93] Saibal Kar,et al. Safety of Percutaneous Left Atrial Appendage Closure: Results From the Watchman Left Atrial Appendage System for Embolic Protection in Patients With AF (PROTECT AF) Clinical Trial and the Continued Access Registry , 2011, Circulation.
[94] P. Karjalainen,et al. Clinical and laboratory risk factors of thrombotic complications after pacemaker implantation: a prospective study. , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[95] S. Russell,et al. Advanced heart failure treated with continuous-flow left ventricular assist device. , 2009, The New England journal of medicine.
[96] Nader Moazami,et al. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. , 2009, Journal of the American College of Cardiology.
[97] M. Schwerzmann,et al. Late results after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism using the amplatzer PFO occluder without intraprocedural echocardiography: effect of device size. , 2009, JACC. Cardiovascular interventions.
[98] O H Frazier,et al. Use of a continuous-flow device in patients awaiting heart transplantation. , 2007, The New England journal of medicine.
[99] E. Foster,et al. Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial. , 2005, Journal of the American College of Cardiology.
[100] J. Steinberg,et al. Intracardiac Ultrasound Detection of Thrombus on Transseptal Sheath: Incidence, Treatment, and Prevention , 2005, Journal of cardiovascular electrophysiology.
[101] G. Lazaros,et al. Early Pacemaker Lead Thrombosis Leading to Massive Pulmonary Embolism , 2004, Echocardiography.
[102] M. Vanderheyden,et al. Thrombosis of a patent foramen ovale closure device: Thrombolytic management , 2002, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[103] C. J. Cooper,et al. Treatment of pacemaker-associated right atrial thrombus with 2-hour rTPA infusion. , 1993, American heart journal.
[104] J. Loike,et al. Complement receptor type three (CD11b/CD18) of human polymorphonuclear leukocytes recognizes fibrinogen. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[105] K. J. May,et al. Streptokinase dissolution of a right atrial thrombus associated with a temporary pacemaker. , 1988, Archives of internal medicine.
[106] S. Goldhaber,et al. Treatment of right atrial thrombus with urokinase. , 1988, American Heart Journal.